Nurix Therapeutics, Inc.

Developing targeted protein degraders across hematologic malignancies, autoimmune disease and neurology.

Back to company catalog

Oncology, immunology & neurology · Targeted protein degradation · Clinical (Phase 2/3)

Compare report options